BACKGROUND: Myocardial beta-adrenergic receptor (beta-AR) signaling is severely impaired in chronic heart failure (HF). This study was conducted to determine if left ventricular (LV) beta-AR signaling could be restored after continuous-flow LV assist device (LVAD) support. METHODS: Twelve patients received LVADs as a bridge to transplant. Paired LV biopsy specimens were obtained at the time of LVAD implant (HF group) and transplant (LVAD group). The mean duration of LVAD support was 152 +/- 34 days. Myocardial beta-AR signaling was assessed by measuring adenylyl cyclase (AC) activity, total beta-AR density (B(max)), and G protein-coupled receptor kinase-2 (GRK2) expression and activity. LV specimens from 8 non-failing hearts (NF) were used as controls. RESULTS: Basal and isoproterenol-stimulated AC activity was significantly lower in HF vs NF, indicative of beta-AR uncoupling. Continuous-flow LVAD support restored basal and isoproterenol-stimulated AC activity to levels similar to NF. B(max) was decreased in HF vs NF and increased to nearly normal in the LVAD group. GRK2 expression was increased 2.6-fold in HF vs NF and was similar to NF after LVAD support. GRK2 activity was 3.2-fold greater in HF vs NF and decreased to NF levels in the LVAD group. CONCLUSIONS: Myocardial beta-AR signaling can be restored to nearly normal after continuous-flow LVAD support. This is similar to previous data for volume-displacement pulsatile LVADs. Decreased GRK2 activity is an important mechanism and indicates that normalization of the neurohormonal milieu associated with HF is similar between continuous-flow and pulsatile LVADs. This may have important implications for myocardial recovery. Copyright 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
BACKGROUND: Myocardial beta-adrenergic receptor (beta-AR) signaling is severely impaired in chronic heart failure (HF). This study was conducted to determine if left ventricular (LV) beta-AR signaling could be restored after continuous-flow LV assist device (LVAD) support. METHODS: Twelve patients received LVADs as a bridge to transplant. Paired LV biopsy specimens were obtained at the time of LVAD implant (HF group) and transplant (LVAD group). The mean duration of LVAD support was 152 +/- 34 days. Myocardial beta-AR signaling was assessed by measuring adenylyl cyclase (AC) activity, total beta-AR density (B(max)), and G protein-coupled receptor kinase-2 (GRK2) expression and activity. LV specimens from 8 non-failing hearts (NF) were used as controls. RESULTS: Basal and isoproterenol-stimulated AC activity was significantly lower in HF vs NF, indicative of beta-AR uncoupling. Continuous-flow LVAD support restored basal and isoproterenol-stimulated AC activity to levels similar to NF. B(max) was decreased in HF vs NF and increased to nearly normal in the LVAD group. GRK2 expression was increased 2.6-fold in HF vs NF and was similar to NF after LVAD support. GRK2 activity was 3.2-fold greater in HF vs NF and decreased to NF levels in the LVAD group. CONCLUSIONS: Myocardial beta-AR signaling can be restored to nearly normal after continuous-flow LVAD support. This is similar to previous data for volume-displacement pulsatile LVADs. Decreased GRK2 activity is an important mechanism and indicates that normalization of the neurohormonal milieu associated with HF is similar between continuous-flow and pulsatile LVADs. This may have important implications for myocardial recovery. Copyright 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Authors: S A Akhter; C A Skaer; A P Kypson; P H McDonald; K C Peppel; D D Glower; R J Lefkowitz; W J Koch Journal: Proc Natl Acad Sci U S A Date: 1997-10-28 Impact factor: 11.205
Authors: Vinay Thohan; Sonny J Stetson; Sherif F Nagueh; Carlos Rivas-Gotz; Michael M Koerner; Javier A Lafuente; Matthias Loebe; George P Noon; Guillermo Torre-Amione Journal: J Heart Lung Transplant Date: 2005-05 Impact factor: 10.247
Authors: A P Kypson; K Peppel; S A Akhter; R E Lilly; D D Glower; R J Lefkowitz; W J Koch Journal: J Thorac Cardiovasc Surg Date: 1998-03 Impact factor: 5.209
Authors: H A Rockman; K R Chien; D J Choi; G Iaccarino; J J Hunter; J Ross; R J Lefkowitz; W J Koch Journal: Proc Natl Acad Sci U S A Date: 1998-06-09 Impact factor: 11.205
Authors: Deepak K Gupta; Hicham Skali; Jose Rivero; Patricia Campbell; Leslie Griffin; Colleen Smith; Courtney Foster; Brian Claggett; Robert J Glynn; Gregory Couper; Michael M Givertz; Mandeep R Mehra; Marcelo Di Carli; Scott D Solomon; Marc A Pfeffer Journal: J Heart Lung Transplant Date: 2014-01-27 Impact factor: 10.247
Authors: Gabriele Giacomo Schiattarella; Fabio Magliulo; Fabio Cattaneo; Giuseppe Gargiulo; Anna Sannino; Anna Franzone; Marco Oliveti; Cinzia Perrino; Bruno Trimarco; Giovanni Esposito Journal: Front Cardiovasc Med Date: 2015-03-16